×

本司产品仅用于科研,不用于临床诊断和治疗

全国免费热线:400-999-2100

您身边的细胞培养专家!

所有分类
  • 所有分类
  • 细胞系
  • 原代细胞
  • 血清
  • 细胞培养基
  • 辅助试剂
  • 细胞凋亡检测试剂盒
  • 细胞房除菌产品
热搜: 胎牛血清 VERO RAW264.7 成纤维细胞 间充质干细胞 上皮细胞

忘记密码

个人邮箱:
验证码: captcha

账号激活

个人邮箱:
×
当前位置:首页 >> 产品中心 >> 细胞资源库 >> 细胞系 >> 

产品中心Cell Resources

联系我们CONTACT US

  • OS-RC-2 (人肾癌细胞) (STR鉴定正确)
  • OS-RC-2 (人肾癌细胞) (STR鉴定正确)
  • OS-RC-2 (人肾癌细胞) (STR鉴定正确)
  • OS-RC-2 (人肾癌细胞) (STR鉴定正确)
  • OS-RC-2 (人肾癌细胞) (STR鉴定正确)
  • OS-RC-2 (人肾癌细胞) (STR鉴定正确)
  • OS-RC-2 (人肾癌细胞) (STR鉴定正确)

OS-RC-2 (人肾癌细胞) (STR鉴定正确)

货号:CL-0177

规格:1×10⁶cells/T25培养瓶

价格: ¥1600

生长培养基:RPMI-164010% FBS1% P/S

数量: - +

  • OS-RC-2 (人肾癌细胞) (STR鉴定正确)
  • OS-RC-2 (人肾癌细胞) (STR鉴定正确)
  • OS-RC-2 (人肾癌细胞) (STR鉴定正确)
  • OS-RC-2 (人肾癌细胞) (STR鉴定正确)
  • OS-RC-2 (人肾癌细胞) (STR鉴定正确)
  • OS-RC-2 (人肾癌细胞) (STR鉴定正确)
  • OS-RC-2 (人肾癌细胞) (STR鉴定正确)

推荐搭配

套餐1:

OS-RC-2 (人肾癌细胞) (STR鉴定正确) ¥1600
OS-RC-2细胞专用培养基
  • ¥350
  • ¥450

现单独购买该产品也可享受限时优惠价!

细胞培养最优解!

套餐组合价:¥1950¥2050

加入购物车

搭配套餐已成功加入购物车!

产品概述
产品信息
名称 OS-RC-2 (人肾癌细胞) (STR鉴定正确)
别称 RC-2
种属
生长特性 贴壁细胞
细胞形态 上皮细胞样
冻存条件 冻存液:55% 基础培养基+40%FBS+5%DMSO 温度:液氮
培养方案A(默认)
生长培养基:
培养条件:
气相:空气,95%;CO2,5%, 温度:37℃
推荐传代比例 1:2-1:4
推荐换液频率 2-3次/周
参考资料(来源文献)
背景描述 OS-RC-2细胞来源于日本人的肾脏肿瘤细胞;OS-RC-2细胞移植到裸鼠可成瘤。
年龄(性别) 男性;52岁
组织来源
细胞类型 肿瘤细胞
肿瘤类型 肾癌细胞
倍增时间 ~60-72 hours
STR鉴定
  • STR位点信息
    Amelogenin X,Y
    CSF1PO 12,13
    D2S1338 20
    D3S1358 17
    D5S818 11,12
    D7S820 10,11
    D8S1179 14
    D13S317 8,12
    D16S539 11
    D18S51 14
    D19S433 13,14
    D21S11 31.2
    FGA 24
    PentaD 11
    PentaE 11,17
    TH01 6
    TPOX 8,11
    vWA 16
    D6S1043 12
    D12S391 20,23
    D2S441 11
  • STR鉴定图
参考文献
文献列表
  • Disulfideptosis-associated lncRNAs reveal features of prognostic, immune escape, tumor mutation, and tumor malignant progression in renal clear cell carcinoma (2024-02-08)

    作者:Xungang Li:1.Department of Urology, Jiu Jiang No. 1 People’s Hospital, Jiujiang, Jiangxi 332000, P.R. China. ; Xinxi Deng:1.Department of Urology, Jiu Jiang No. 1 People’s Hospital, Jiujiang, Jiangxi 332000, P.R. China. ; Taobin Liu:1.Department of Urology, Jiu Jiang No. 1 People’s Hospital, Jiujiang, Jiangxi 332000, P.R. China. ; Wensheng Zhang:1.Department of Urology, Jiu Jiang No. 1 People’s Hospital, Jiujiang, Jiangxi 332000, P.R. China. ; Jin Tao:1.Department of Pediatric, Jiujiang University Affiliated Hospital, Jiujiang, Jiangxi 332000, P.R. China. ;

    期刊:Disulfideptosis-associated lncRNAs reveal features of prognostic, immune escape, tumor mutation, and tumor malignant progression in renal clear cell carcinoma

    DOI:10.18632/aging.205534

    影响因子 :5.2

    引用产品: 786-O [786-0] 细胞 ,  OS-RC-2 细胞 ,  A-498 细胞 ,  ACHN 细胞 ,  HK-2 细胞

  • Identify CTBP1-DT as an immunological biomarker that promotes lipid synthesis and apoptosis resistance in KIRC (2024-03-21)

    作者:Haolin Li:1.Department of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei, China. ; Mintian Fei:1.Department of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei, China. ; Yi Zhang:1.Department of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei, China. ; Qili Xu:1.Department of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei, China. ; Rui Feng:1.Department of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei, China. ; Jing Cao:1.Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China. Electronic address: 2575241418@qq.com. ; Yan Qu:1.Department of Pathogenic Biology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China. Electronic address: 382917561@qq.com. ; Haibing Xiao:1.Department of Urology, Th

    期刊:Identify CTBP1-DT as an immunological biomarker that promotes lipid synthesis and apoptosis resistance in KIRC

    DOI:10.1016/j.gene.2024.148403

    影响因子 :3.5

    引用产品: HK-2 细胞 ,  ACHN 细胞 ,  A-498 细胞 ,  786-O [786-0] 细胞 ,  OS-RC-2 细胞 ,  Caki-1 细胞 ,  RPMI-1640 培养基 ,  MEM 培养基

  • Mutual regulation between TRIM21 and TRIM8 via K48-linked ubiquitination (2023-11-01)

    作者:Lin Wang:1.Beijing Institute of Basic Medical Sciences, 100850, Beijing, China. ; Hui Li:1.Beijing Institute of Basic Medical Sciences, 100850, Beijing, China. ; Aixue Huang:1.Beijing Institute of Basic Medical Sciences, 100850, Beijing, China. ; Yuechao Zhao:1.Beijing Institute of Basic Medical Sciences, 100850, Beijing, China. ; Can Xiao:1.Beijing Institute of Basic Medical Sciences, 100850, Beijing, China. ; Jie Dong:1.Beijing Institute of Basic Medical Sciences, 100850, Beijing, China. ; Xuemei Liu:1.Beijing Institute of Basic Medical Sciences, 100850, Beijing, China. liuxuemei@bmi.ac.cn. ; Ningsheng Shao:1.Beijing Institute of Basic Medical Sciences, 100850, Beijing, China. shaoningsheng@bmi.ac.cn. ;

    期刊:Mutual regulation between TRIM21 and TRIM8 via K48-linked ubiquitination

    DOI:10.1038/s41388-023-02879-0

    影响因子 :8.0

    引用产品: A549 [A-549] 细胞 ,  NCI-H1299 细胞 ,  786-O [786-0] 细胞 ,  OS-RC-2 细胞 ,  293T [HEK-293T] 细胞 ,  BEAS-2B 细胞 ,  McCoy's 5A 培养基

  • HOXD8 suppresses renal cell carcinoma growth by upregulating SHMT1 expression (2023-09-26)

    作者:Yang Yang:1.School of Pharmacy, Binzhou Medical University, Yantai, China. ; 2.Shandong Technology Innovation Center of Molecular Targeting and Intelligent Diagnosis, and Treatment, Binzhou Medical University, Yantai, China. ; Minghui Zhang:1.School of Pharmacy, Binzhou Medical University, Yantai, China. ; 2.Shandong Technology Innovation Center of Molecular Targeting and Intelligent Diagnosis, and Treatment, Binzhou Medical University, Yantai, China. ; Yaxuan Zhao:1.School of Pharmacy, Binzhou Medical University, Yantai, China. ; 2.Shandong Technology Innovation Center of Molecular Targeting and Intelligent Diagnosis, and Treatment, Binzhou Medical University, Yantai, China. ; Tingzhi Deng:1.School of Pharmacy, Binzhou Medical University, Yantai, China. ; 2.Shandong Technology Innovation Center of Molecular Targeting and Intelligent Diagnosis, and Treatment, Binzhou Medical University, Yantai, China. ; Xiang Zhou:1.School of Pharmacy, Binzhou Medical University, Yantai, China. ; 2

    期刊:HOXD8 suppresses renal cell carcinoma growth by upregulating SHMT1 expression

    DOI:10.1111/cas.15982

    影响因子 :5.7

    引用产品: OS-RC-2 细胞 ,  ACHN 细胞

  • Root extract of Hemsleya amabilis Diels suppresses renal cell carcinoma cell growth through inducing apoptosis and G2/M phase arrest via PI3K/AKT signaling pathway activation (2023-08-07)

    作者:Kai Li:1.Guizhou Provincial Key Laboratory for Rare Animal and Economic Insect of the Mountainous Region, College of Biology and Environmental Engineering, Guiyang University, Guiyang, 550025, China. ; Ganhua You:1.The Second People's Hospital of Guizhou Province, Guiyang, 550002, China. ; Kehua Jiang:1.Department of Urology, Guizhou Provincial People's Hospital, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou Province, 550002, China. ; Rongpin Wang:1.Department of Radiology, Guizhou Provincial People's Hospital, Guiyang, Guizhou, 550002, China. ; Wuchao Li:1.Department of Radiology, Guizhou Provincial People's Hospital, Guiyang, Guizhou, 550002, China. ; Yonglu Meng:1.Guizhou Provincial Key Laboratory for Rare Animal and Economic Insect of the Mountainous Region, College of Biology and Environmental Engineering, Guiyang University, Guiyang, 550025, China. ; Yinyi Fang:1.Medical College of Guizhou University, Guiyang, Guizhou Province, 550025, China. ; We

    期刊:Root extract of Hemsleya amabilis Diels suppresses renal cell carcinoma cell growth through inducing apoptosis and G2/M phase arrest via PI3K/AKT signaling pathway activation

    DOI:10.1016/j.jep.2023.117014

    影响因子 :5.4

    引用产品: McCoy's 5A完全培养基 (含10%FBS) ,  MEM完全培养基 (含NEAA、10%FBS) ,  OS-RC-2 细胞 ,  ACHN 细胞

  • Based on disulfidptosis, revealing the prognostic and immunological characteristics of renal cell carcinoma with tumor thrombus of vena cava and identifying potential therapeutic target AJAP1 (2023-05-29)

    作者:Lin Yang:1.Department of Urology, First Affiliated Hospital of Nanchang University, Nanchang, 330000, China. ; Jiahao Liu:1.Department of Urology, First Affiliated Hospital of Nanchang University, Nanchang, 330000, China. ; Sheng Li:1.Department of Urology, First Affiliated Hospital of Nanchang University, Nanchang, 330000, China. ; Xiaoqiang Liu:1.Department of Urology, First Affiliated Hospital of Nanchang University, Nanchang, 330000, China. ; Fuchun Zheng:1.Department of Urology, First Affiliated Hospital of Nanchang University, Nanchang, 330000, China. ; Songhui Xu:1.Department of Urology, First Affiliated Hospital of Nanchang University, Nanchang, 330000, China. ; Bin Fu:1.Department of Urology, First Affiliated Hospital of Nanchang University, Nanchang, 330000, China. urofbin@163.com. ; Jing Xiong:1.Department of Urology, First Affiliated Hospital of Nanchang University, Nanchang, 330000, China. alex7023@126.com. ;

    期刊:Based on disulfidptosis, revealing the prognostic and immunological characteristics of renal cell carcinoma with tumor thrombus of vena cava and identifying potential therapeutic target AJAP1

    DOI:10.1007/s00432-023-04877-x

    影响因子 :3.6

    引用产品: HK-2 细胞 ,  Caki-1 细胞 ,  OS-RC-2 细胞

  • Construction and Validation of a Novel Cuproptosis-Related Seven-lncRNA Signature to Predict the Outcomes, Immunotherapeutic Responses, and Targeted Therapy in Patients with Clear Cell Renal Cell Carcinoma (2023-01-25)

    作者:Haoxun Zhang:1.First Affiliated Hospital of Harbin Medical University, Harbin, China. ; Zikuan Ning:1.First Affiliated Hospital of Harbin Medical University, Harbin, China. ; Bowen Wang:1.First Affiliated Hospital of Harbin Medical University, Harbin, China. ; Yiwen Liu:1.First Affiliated Hospital of Harbin Medical University, Harbin, China. ; Boju Tao:1.First Affiliated Hospital of Harbin Medical University, Harbin, China. ; Guoling Zhang:1.First Affiliated Hospital of Harbin Medical University, Harbin, China. ; Hua Liu:1.First Affiliated Hospital of Harbin Medical University, Harbin, China. ; Chunyang Wang:1.First Affiliated Hospital of Harbin Medical University, Harbin, China. ;

    期刊:Construction and Validation of a Novel Cuproptosis-Related Seven-lncRNA Signature to Predict the Outcomes, Immunotherapeutic Responses, and Targeted Therapy in Patients with Clear Cell Renal Cell Carcinoma

    DOI:10.1155/2023/7219794

    影响因子 :3.5

    引用产品: A-498 细胞 ,  OS-RC-2 细胞

  • P4HA3 promotes clear cell renal cell carcinoma progression via the PI3K/AKT/GSK3β pathway (2023-01-02)

    作者:Zhechuan Zhang:1.Department of Urology, The Second Affiliated Hospital of Chongqing Medical University, 74 Linjiang Road, Yuzhong District, Chongqing, China. ; 2.The Second Clinical College, Chongqing Medical University, Chongqing, China. ; Yuanfeng Zhang:1.Department of Urology, The Second Affiliated Hospital of Chongqing Medical University, 74 Linjiang Road, Yuzhong District, Chongqing, China. 304100@cqmu.edu.cn. ; Ronggui Zhang:1.Department of Urology, The Second Affiliated Hospital of Chongqing Medical University, 74 Linjiang Road, Yuzhong District, Chongqing, China. zrgcqmu@126.com. ; 2.Department of Urology, Chongqing University Central Hospital, Chongqing University, 1 Jiankang Road, Yuzhong District, Chongqing, China. zrgcqmu@126.com. ;

    期刊:P4HA3 promotes clear cell renal cell carcinoma progression via the PI3K/AKT/GSK3β pathway

    DOI:10.1007/s12032-022-01926-2

    影响因子 :3.4

    引用产品: OS-RC-2 细胞 ,  786-O [786-0] 细胞 ,  ACHN 细胞 ,  769-P 细胞 ,  Caki-1 细胞

  • Downregulation of NEBL promotes migration and invasion of clear cell renal cell carcinoma by inducing epithelial-mesenchymal transition (2023-12-29)

    作者:Ran Zhao:1.Life Science Institute, Guangxi Medical University, China; Key Laboratory of High-Incidence-Tumor Prevention & Treatment (Guangxi Medical University), Ministry of Education, Nanning, China. ; Ziyuan Liang:1.Life Science Institute, Guangxi Medical University, China; Key Laboratory of High-Incidence-Tumor Prevention & Treatment (Guangxi Medical University), Ministry of Education, Nanning, China. ; Jiemei Chu:1.Life Science Institute, Guangxi Medical University, China. ; Qian Zheng:1.Life Science Institute, Guangxi Medical University, China; Key Laboratory of High-Incidence-Tumor Prevention & Treatment (Guangxi Medical University), Ministry of Education, Nanning, China. ; Jun Zhao:1.Key Laboratory of High-Incidence-Tumor Prevention & Treatment (Guangxi Medical University), Ministry of Education, Nanning, China. ; Shiyue Tang:1.Key Laboratory of High-Incidence-Tumor Prevention & Treatment (Guangxi Medical University), Ministry of Education, Nanning, China. ; Qiaoli Chen:1.

    期刊:Downregulation of NEBL promotes migration and invasion of clear cell renal cell carcinoma by inducing epithelial-mesenchymal transition

    DOI:10.1016/j.prp.2023.155068

    影响因子 :2.8

    引用产品: 293T [HEK-293T] 细胞 ,  786-O [786-0] 细胞 ,  OS-RC-2 细胞

  • Spindle pole body component 24 homolog potentiates tumor progression via regulation of SRY-box transcription factor 2 in clear cell renal cell carcinoma (2001-02-20)

    作者:Chengfang Sun:1.Department of Urology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China. ; Jingchao Wei:1.Department of Urology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China. ; Zhilin Long:1.Key Laboratory of Growth Regulation and Translational Research of Zhejiang Province, School of Life Sciences, Westlake University, Hangzhou, China. ; 2.Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou, China. ; 3.Institute of Basic Medical Sciences, Westlake Institute for Advanced Study, Hangzhou, China. ; Weixi Zhao:1.Key Laboratory of Growth Regulation and Translational Research of Zhejiang Province, School of Life Sciences, Westlake University, Hangzhou, China. ; 2.Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou, China. ; 3.Institute of Basic Medical Sciences, Westlake Institute for Advanced Study, Hangzhou, China. ; Qi Huangfu:1.Department of Urology, The Second Affiliated Hospit

    期刊:Spindle pole body component 24 homolog potentiates tumor progression via regulation of SRY-box transcription factor 2 in clear cell renal cell carcinoma

    DOI:10.1096/fj.202101310R

    影响因子 :4.8

    引用产品: OS-RC-2 细胞 ,  Caki-1 细胞

  • Circ_0000069 contributes to the growth, metastasis and glutamine metabolism in renal cell carcinoma (RCC) via regulating miR-125a-5p-dependent SLC1A5 expression (2022-11-30)

    作者:Liqing Yang:1.Department of Neurology, Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai City, Shandong Province, China. ; Lin Wang:1.Department of Urology, Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai City, Shandong Province, China. ; Jitao Wu:1.Department of Urology, Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai City, Shandong Province, China. ; Yongqiang Wang:1.Department of Urology, Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai City, Shandong Province, China. Electronic address: vabamyy@163.com. ;

    期刊:Circ_0000069 contributes to the growth, metastasis and glutamine metabolism in renal cell carcinoma (RCC) via regulating miR-125a-5p-dependent SLC1A5 expression

    DOI:10.1016/j.trim.2022.101764

    影响因子 :2.0

    引用产品: HK-2 细胞 ,  OS-RC-2 细胞 ,  ACHN 细胞 ,  786-O [786-0] 细胞

  • 点击展开收起列表
FAQs

Q:{{item.question}}

A:

暂无数据
产品资料
注:百度浏览器无法支持扫一扫功能,请输入识别码,获取相应产品资料

识别码示意图

确定
邱国娜/胡文君

邱国娜/胡文君

【 上海 】

何帆

何帆

【 陕西、甘肃、宁夏、青海、新疆 】

 熊经理

熊经理

【 海南 】

朱莎莉

朱莎莉

【 湖北 】

刘本佳

刘本佳

【江苏(除南京外)】

章臣雄

章臣雄

【 广州 】

杜焱炜

杜焱炜

【 四川、云南、西藏 】

田博浩

田博浩

【 重庆、贵州 】

石文平

石文平

【 北京、辽宁 】

胡文君

胡文君

【江西】

李荣枫

李荣枫

【 天津、河北、内蒙古、山西 】

陈雨兰

陈雨兰

【 山东 】

尹国文

尹国文

【浙江】

唐小花

唐小花

【 吉林、黑龙江 】

付帅

付帅

【 安徽 】

朱俊宇

朱俊宇

【 河南、广西 】

李庆祖

李庆祖

【 湖南 】

熊志亮

熊志亮

【 深圳 】

梅文强

梅文强

【福建】

林钊光

林钊光

【南京】

微信扫一扫咨询

微信扫一扫咨询

在线客服
关闭
在线咨询

关注微信公众号